Essays about: "MERGER CASE STUDY astrazeneca"
Found 3 essays containing the words MERGER CASE STUDY astrazeneca.
-
1. The Consequences of Post-Merger & Acquisition Performance in Listed and Non-Listed Companies in Sweden : a Case Study for AstraZeneca AB, Cybercom Group AB, Grant Thornton Sweden AB and PayEx
University essay from Institutionen för humaniora och samhällsvetenskapAbstract : Empirical research findings on the consequences of post-M&A performance have generated several result, although most of which are inconsistent. The relation of such post-M&A performances to non-listed and listed companies can be relative especially when considering the companies economic and financial structure and other prevailing factors associated to the host country. READ MORE
-
2. Are Mergers and Acquisitions a Successful Way of Growth - A Case Study of Astra Zeneca
University essay from Sektionen för ekonomi och teknik (SET)Abstract : Title: Are Mergers and Acquisitions a successful way of growth- A Case Study of AstraZeneca Subject: Bachelors thesis within the field of Business Management, School of Economics and Engineering, Halmstad University, Sweden Authors: Frida Ekenberg & Simon Utas Supervisor: Christer Norr Objective: The objective of this thesis is to analyse the effects of a fusion from a business perspective. Furthermore, a case study approach is used in order to identify factors that have been reached by AstraZeneca through the joint venture. READ MORE
-
3. Merger and acquisition between small biotech and large pharmaceutical companies - a winning combination? : Case study on the acquisitions of CAT by AstraZeneca and Abgenix by Amgen; MBA thesis in marketing
University essay from Institutionen för ekonomiAbstract : This study aims at introducing and describing a novel multi parameter analysis method to identify potential acquisition targets and to qualitatively and quantitatively evaluate the overall match between a target company and its acquirer. The method was tested with two recent real cases involving each an antibody based biotech company and a large fully integrated pharmaceutical company. READ MORE